Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
BROOKS LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 3.85-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 3.85 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20243.85
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2024 3.85
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹322.4 Cr 4.9% -29.8% -3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,569.0 Cr 2.8% -7.5% 2.3% Stock Analytics
DIVIS LABORATORIES ₹146,318.0 Cr -0.2% -9.9% 60.4% Stock Analytics
CIPLA ₹118,110.0 Cr 4.4% -0.6% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,926.0 Cr 4.8% -2.9% 15.4% Stock Analytics
DR REDDYS LABORATORIES ₹93,471.5 Cr NA -9.4% -10.2% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

4.9%

-29.8%

-3.7%

SENSEX

1.4%

-5.3%

0.3%


You may also like the below Video Courses